Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00013364 · ClinicalTrials.gov registry record

Effects of Stimulus Validity on Speech Recognition

A clinical trial of Hearing Impaired, sponsored by US Department of Veterans Affairs.

Completed
Registry status
80
Enrollment target
1
Study location

NCT00013364: Completed study of Hearing Impaired, sponsored by US Department of Veterans Affairs.

NCT00013364 is a study of Hearing Impaired that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00013364, a study of Hearing Impaired, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The effects of talker variability will be investigated with four groups of listeners (young normal-hearing; old normal-hearing; young hearing-impaired; old hearing-impaired). Experimental conditions will include between-talker differences, speaking rate, lexical difficult and semantic/linguistic context. A preliminary experiment will evaluate the relative merit of adaptive vs fixed-level methods of stimulus presentation.

Conditions Studied

Interventions

  • BEHAVIORAL Talker variability

Study Locations (1)

California

  • VAMC, West Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 1998-04
Est. Completion 2001-03
US Department of Veterans Affairs

632 total trials

What the finished NCT00013364 record still lists

NCT00013364 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.

The record links to 1 condition, with Hearing Impaired appearing as the primary indexed condition, and to 1 intervention - of which Talker variability is the first listed.

NCT00013364 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00013364 about?

NCT00013364 is a clinical study titled "Effects of Stimulus Validity on Speech Recognition". The effects of talker variability will be investigated with four groups of listeners (young normal-hearing; old normal-hearing; young hearing-impaired; old hearing-impaired). Experimental conditions will include between-talker differences, speaking rate, lexical difficult and semantic/linguistic con...

What is the current status of trial NCT00013364?

This trial is currently completed. The enrollment target is 80 participants. The study started on 1998-04. Estimated completion is 2001-03.

What conditions does trial NCT00013364 study?

This clinical trial studies the following conditions: Hearing Impaired.

What interventions are being tested in trial NCT00013364?

The interventions under investigation include: Talker variability (BEHAVIORAL).

Who is sponsoring clinical trial NCT00013364?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00013364 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Impaired

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00013364, the US trial registry maintained by the National Library of Medicine. NCT00013364 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.